Biocompatibility News

21 May 2024

A new scientific study strengthens and validates the BCI’s Facta Technology

A relevant scientific study by BCI and authored by Filippo Naso, Alessandro Gandaglia, Giulio Sturaro, Cesare Galli, and Robert J. Melder has just been published in Frontiers in Bioscience-Landmark journal to further validate the scientific basis of BCI’s technology for ensuring the long-lasting biocompatibility of implantable biological tissues. The study, titled “The α-Gal KO Mouse […]


3 October 2021

Interview to Alessandro Gandaglia, CEO of BCI (Rai IsoRadio)

In the interview realized by Roberto Poletti for Rai IsoRadio, Alessandro Gandaglia (CEO of BCI) explains how his company was born and how they realized a new and innovative technology completely ‘made in Italy’. The product developed by BCI (Biocompatibility Innovation) is unique, with an impressive potential to improve patients’ life and contribute to reducing […]


16 September 2020

FACTA®, the technology that doubles the life of heart valves

A Made in Italy technology that allows the doubling of the life of biological heart valves. The solution was developed by BCI, the innovative company led by Alessandro Gandaglia, Filippo Naso and Ugo Stefanelli. The team of researchers developed the Facta method, a patent on which the attention of large American and Chinese companies that […]


15 August 2020

The Italian startup that doubles the lifecycle of heart valves (Fortune)

«Our company BCI has entered into negotiations with the two main industrial partners in the field of biological heart valves – in terms of sales volume» declared Alessandro Gandaglia, CEO of BCI to Fortune. The greatest benefits of the FACTA Technology developed by BCI are the reduction by 20-30% of the valve replacement surgeries and its […]


30 May 2020

BCI joins Unismart, the community that promotes the technology transfer and innovation

Eighty-five highly specialized ventures including companies, research centers, and trade associations. Over 70 valued patents. A community where cross-contamination of ideas generates new business projects. A great environment for BCI – Biocompatibility Innovation, which became part of Unismart since May 2020. Unismart is the Foundation of the University of Padua, born to promote the technology […]


7 May 2019

The G-Factor of BCI: Collaboration with the Golinelli Foundation

May 2019. BCI, BioCompatibility Innovation, is among the first innovative startups selected to be part of G-Factor, the new space of the Golinelli Foundation, inaugurated last February in Bologna. The Padua-based startup joins the elite group of nine startups and one competence center, the first “tenants” of the five thousand square meters of the new […]


10 July 2017

An innovative treatment to double the lifespan of cardiac valve substitutes.

July 2017. An innovative treatment to double the lifespan of animal-derived cardiac valve substitutes. This is what BCI, BioCompatibility Innovation, an innovative startup based in Padua, is developing. It involves two biologists with academic experience and has already secured €700,000 in funding. In September, the first official trial will begin in collaboration with the Policlinico […]